Myriad Genetics | MYGN - Gross Profit On Sales


Myriad Genetics reported $146.8M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Illumina USD 759M 26M Dec/2025
J&J USD 17.24B 642M Mar/2026
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Standard Biotools USD 11.38M 1.9M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Veracyte USD 101.97M 10.69M Dec/2025
Waters USD 557.42M 97.44M Dec/2025